Leerink Partners Initiates Coverage on Mind Medicine (MindMed) (NASDAQ:MNMD)
Leerink Partners began coverage on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a report released on Monday, StockNewsAPI reports. The firm issued an outperform rating and a $20.00 price objective on the stock. Several other brokerages have also commented on MNMD. Roth Mkm assumed coverage on Mind Medicine (MindMed) in a report […]
More Stories
Insider Selling: IonQ, Inc. (NYSE:IONQ) CRO Sells $98,184.48 in Stock
IonQ, Inc. (NYSE:IONQ – Get Free Report) CRO Rima Alameddine sold 9,159 shares of the business’s stock in a transaction...
Mathew Kirschner Buys 5,380 Shares of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE:RQI) Stock
Cohen & Steers Quality Income Realty Fund, Inc. (NYSE:RQI – Get Free Report) Portfolio Manager Mathew Kirschner acquired 5,380 shares...
TD Cowen Raises Quanta Services (NYSE:PWR) Price Target to $335.00
Quanta Services (NYSE:PWR – Free Report) had its price objective boosted by TD Cowen from $280.00 to $335.00 in a...
Moody’s (NYSE:MCO) Price Target Raised to $464.00
Moody’s (NYSE:MCO – Free Report) had its price target raised by BMO Capital Markets from $455.00 to $464.00 in a...
Barclays Cuts PagSeguro Digital (NYSE:PAGS) Price Target to $13.00
PagSeguro Digital (NYSE:PAGS – Free Report) had its price objective reduced by Barclays from $16.00 to $13.00 in a report...
Aflac Incorporated (NYSE:AFL) Given Average Rating of “Hold” by Brokerages
Shares of Aflac Incorporated (NYSE:AFL – Get Free Report) have earned a consensus rating of “Hold” from the fifteen analysts...